Jaroslav A. Hubáček
-
CD14 Polymorphism Is Not Associated with SARS-CoV-2 Infection in Central European Population
Jaroslav A. Hubáček, Tom Philipp, Ondřej Májek, Dana Dlouhá, Věra Adámková, Ladislav Dušek
2023, Vol. 69, Issue 5-6, pp. 181-185 -
Nobody Is Perfect: Comparison of the Accuracy of PCR-RFLP and KASP™ Method for Genotyping. ADH1B and FTO Polymorphisms as Examples
Jaroslav A. Hubáček, H. Pikhart, A. Peasey, R. Kubínová, M. Bobák
2015, Vol. 61, Issue 4, pp. 156-160 -
Tagging rs10811661 Variant at CDKN2A/2B Locus Is Not Associated with Type 2 Diabetes Mellitus in Czech Population
Jaroslav A. Hubáček, T. Neškudla, M. Klementová, V. Adámková, T. Pelikánová
2013, Vol. 59, Issue 4, pp. 168-171 -
Association between a Marker on Chromosome 9 and Acute Coronary Syndrome Confirmatory Study on Czech Population
Jaroslav A. Hubáček, V. Staněk, M. Gebauerová, R. Poledne, M. Aschermann, H. Skalická, J. Matoušková, A. Kruger, M. Pěnička, H. Hrabáková, J. Veselka, P. Hájek, V. Lánská, V. Adámková, J. Piťha
2012, Vol. 58, Issue 5, pp. 203-208 -
INSIG2 G-102A Promoter Variant Exhibits Context-Dependent Effect on HDL-Cholesterol Levels but Not on BMI in Caucasians
Jaroslav A. Hubáček, P. Suchánek, V. Lánská, J. Piťha, V. Adámková
2011, Vol. 57, Issue 4, pp. 170-172 -
INSIG2 Promoter Variant, Obesity Markers and Lipid Parameters – No Association in a Large Slavonic Caucasian Population Sample
Jaroslav A. Hubáček, L. Kuthanová, R. Bohuslavová, V. Adámková, V. Lánská, T. Meitinger, A. Pfeufer
2010, Vol. 56, Issue 3, pp. 131-134 -
Apolipoprotein E Arg136 → Cys in Individuals with Premature Myocardial Infarction
Jaroslav A. Hubáček, R. Poledne, J. Piťha, M. Aschermann, H. Skalická, V. Staněk
2009, Vol. 55, Issue 3, pp. 116-118
The following name might also represent this author:
J. A. Hubáček
-
Genetics of T2DM and Its Chronic Complications: Are We Any Closer to the Individual Prediction of Genetic Risk?
D. Galuška, Lucie Dlouhá, J. A. Hubáček, K. Kaňková
2022, Vol. 68, Issue 5-6, pp. 159-179 -
Genetic Markers at ANRIL, FTO and 2q36.3 Locus in Czech Patients Undergoing Coronary Artery Bypass Graft Surgery
Petr Kačer, J. Pirk, V. Lánská, J. A. Hubáček, V. Adámek, T. Červinková, J. Bělohoubek, O. Auzký, V. Adámková
2020, Vol. 66, Issue 4, pp. 148-153 -
Strong Association between APOA5 Gene Polymorphisms and Hypertriglyceridaemic Episodes
Michal Vrablík, J. A. Hubáček, D. Dlouha, M. Satny, V. Adámková, R. Ceska
2019, Vol. 65, Issue 4, pp. 188-194 -
Can Leukocyte Telomere Length Predict Survival Time in Heart Transplant Recipients over a Minimal Follow-Up of 20 years?
Dana Dlouhá, V. Vančura, J. Vymětalová, J. A. Hubáček, V. Lánská, I. Málek
2016, Vol. 62, Issue 5, pp. 188-193 -
MTHFR and HFE, but Not Preproghrelin and LBP, Polymorphisms as Risk Factors for All-Cause End-Stage Renal Disease Development
Silvie Bloudíčková, L. Kuthanová, J. A. Hubáček
2014, Vol. 60, Issue 2, pp. 83-88 -
Polymorphisms in IFN-γ, TNF-α and IL-10 in Patients on Maintenance Haemodialysis
Silvie Bloudíčková, L. Kuthanová, J. A. Hubáček
2011, Vol. 57, Issue 1, pp. 30-34 -
Why We Are Not Able to Find the Coronary Heart Disease Gene – apoE As an Example
Rudolf Poledne, J. A. Hubáček, V. Staněk, M. Aschermann, J. Matoušková, J. Veselka, P. Widimský, R. Cífková, V. Lánská, J. Piťha
2010, Vol. 56, Issue 5, pp. 218-222
